PRSS53
Basic information
Region (hg38): 16:31083437-31089628
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PRSS53 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 36 | 39 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 36 | 3 | 1 |
Variants in PRSS53
This is a list of pathogenic ClinVar variants found in the PRSS53 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-31084143-G-A | not specified | Uncertain significance (Feb 15, 2023) | ||
16-31084167-C-T | not specified | Uncertain significance (Jul 19, 2022) | ||
16-31084173-A-G | not specified | Uncertain significance (Jul 26, 2022) | ||
16-31084223-G-A | not specified | Uncertain significance (Jun 22, 2024) | ||
16-31084266-C-T | not specified | Uncertain significance (Aug 17, 2022) | ||
16-31084281-C-T | not specified | Uncertain significance (Aug 13, 2021) | ||
16-31084298-C-T | not specified | Uncertain significance (Dec 06, 2021) | ||
16-31084322-G-T | not specified | Uncertain significance (Aug 11, 2022) | ||
16-31084620-C-T | not specified | Uncertain significance (Dec 09, 2023) | ||
16-31084638-C-T | not specified | Likely benign (May 05, 2023) | ||
16-31084658-C-G | not specified | Uncertain significance (Oct 26, 2022) | ||
16-31084797-C-T | not specified | Uncertain significance (Aug 26, 2022) | ||
16-31084910-C-A | not specified | Uncertain significance (Sep 26, 2022) | ||
16-31084924-C-G | not specified | Uncertain significance (Dec 31, 2023) | ||
16-31084935-G-A | not specified | Uncertain significance (Apr 04, 2024) | ||
16-31084980-G-A | not specified | Uncertain significance (Jun 16, 2023) | ||
16-31084999-C-T | not specified | Uncertain significance (Mar 11, 2024) | ||
16-31085022-C-T | not specified | Uncertain significance (Jan 10, 2022) | ||
16-31085121-G-A | Likely benign (Jan 01, 2023) | |||
16-31085168-A-G | not specified | Uncertain significance (Apr 11, 2023) | ||
16-31085219-G-A | not specified | Uncertain significance (Apr 06, 2024) | ||
16-31086004-G-C | not specified | Uncertain significance (Jul 14, 2021) | ||
16-31086125-C-G | not specified | Uncertain significance (Oct 27, 2023) | ||
16-31086145-G-C | not specified | Uncertain significance (Sep 20, 2023) | ||
16-31086153-C-G | not specified | Uncertain significance (Aug 02, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PRSS53 | protein_coding | protein_coding | ENST00000280606 | 11 | 6204 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
9.35e-17 | 0.00927 | 124655 | 0 | 163 | 124818 | 0.000653 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.485 | 294 | 318 | 0.923 | 0.0000185 | 3463 |
Missense in Polyphen | 109 | 133.02 | 0.81941 | 1515 | ||
Synonymous | -0.0345 | 131 | 131 | 1.00 | 0.00000804 | 1155 |
Loss of Function | 0.113 | 25 | 25.6 | 0.976 | 0.00000117 | 275 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00471 | 0.00468 |
Ashkenazi Jewish | 0.00221 | 0.00219 |
East Asian | 0.000171 | 0.000167 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000396 | 0.000388 |
Middle Eastern | 0.000171 | 0.000167 |
South Asian | 0.000232 | 0.000229 |
Other | 0.000499 | 0.000495 |
dbNSFP
Source:
- Function
- FUNCTION: In vitro can degrade the fibrinogen alpha chain of as well as pro-urokinase-type plasminogen activator. {ECO:0000269|PubMed:16566820}.;
Intolerance Scores
- loftool
- rvis_EVS
- -0.69
- rvis_percentile_EVS
- 15.2
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.144
- ghis
- 0.510
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | High | Medium | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Prss53
- Phenotype
Gene ontology
- Biological process
- proteolysis
- Cellular component
- extracellular region;cytoplasm
- Molecular function
- serine-type endopeptidase activity